Basic & Clinical Medicine ›› 2013, Vol. 33 ›› Issue (7): 793-798.

Previous Articles     Next Articles

S100A6 upregulate β-catenin and its mechanism in human breast cancer cell MCF-7

  

  • Received:2012-05-29 Revised:2012-09-20 Online:2013-07-05 Published:2013-06-26

Abstract: To investigate the impact of S100A6 on β-catenin and its molecular mechanism in human breast cancer cell line MCF-7. Methods MCF-7 cells were infected by recombinant adenoviruses carrying human S100A6 and its siRNA gene, AdS100A6 and AdsiS100A6 respectively. RT-PCR,Western blot and immunocytochemistry were used to detect expression and/or distribution of β-catenin,E-cadherin and p-GSK3β. Results In MCF-7 cells, S100A6 increased the protein level of β-catenin(P<0.01),but no significant difference in transcriptional level of β-catenin between S100A6 group and control group(GFP group)(P>0.05); The mRNA,protein level and distribution of E-cadherin had no significant difference between S100A6 group and control group(P>0.05); S100A6 increased phosphorylation of GSK3β(P<0.01).Conclusion S100A6 may upregulate β-catenin by promoting phosphorylation of GSK3β,rather than via effect on E-cadherin.

Key words: S100A6, β-catenin, E-cadherin, GSK3β

CLC Number: